Session » Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics
-
Abstract Number: 692
A Phase 1 Multicenter, Open-Label Study of MEDI-546, a Human Anti-Type I Interferon Receptor Monoclonal Antibody, in Adults with Scleroderma
-
Abstract Number: 693
A Placebo-Controlled Phase II Study of Hyperimmune Caprine Serum in Diffuse Cutaneous Systemic Sclerosis: Safety and Potential Efficacy
-
Abstract Number: 694
Nilotinib (Tasigna™) in the Treatment of Early Diffuse Systemic Sclerosis: A Single Group, Open Label Pilot Clinical Trial
-
Abstract Number: 695
Comparison of Intense Pulsed Light and Laser Treatment of Telangiectases in Systemic Sclerosis
-
Abstract Number: 696
Risk Factors for EARLY Mortality in Scleroderma Patients: A Report From the EULAR Scleroderma Trials and Research Group (EUSTAR) Database
-
Abstract Number: 697
Demographic, Clinical, Serologic and Socioeconomic Measures Each Predict Mortality in Scleroderma
-
Abstract Number: 698
External Validation of a Two-Year Mortality Risk Prediction Rule in Early Diffuse Systemic Sclerosis Patients
-
Abstract Number: 699
Endothelial Dysfunction and Vascular Stiffness in Early Diffuse Systemic Sclerosis
-
Abstract Number: 700
Clinical Correlation of Flow-Mediated Endothelium-Dependent Vasodilatation in Systemic Sclerosis
-
Abstract Number: 701
Vascular Differences Associated to Genetic Polymorphisms of Endothelial Nitric Oxide Synthase in Mexican Patients with Systemic Sclerosis. A Preliminary Report
-
Abstract Number: 702
Arterial Stiffness Is Increased in Systemic Sclerosis: A Cross-Sectional Comparison with Matched Controls
-
Abstract Number: 703
Vascular Ischemic Events in Systemic Sclerosis – A Cross-Sectional Comparision with Population-based Controls
-
Abstract Number: 704
Decreased Number of Endothelial Progenitor Cells in Systemic Sclerosis Patients with Early Disease
-
Abstract Number: 705
Adipose Derived Stem Cells As an Alternative Source of Cellular Repair for Vascular Dysfunction in Systemic Sclerosis
-
Abstract Number: 706
Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis
-
Abstract Number: 707
Risk of Cancer in Systemic Sclerosis: Meta-Analysis of Population-Based Cohort Studies
-
Abstract Number: 708
Histological Features of Localized Scleroderma‘en Coup De Sabre‘: A Study of 16 Cases
-
Abstract Number: 709
Fingertip Skin Hardness in Limited Scleroderma: Durometry versus Manual Assessment
-
Abstract Number: 710
Optical Density Measure of the Papillary Dermis Discriminates As Abnormal Clinically Uninvolved Skin in Systemic Sclerosis and Correlates with Severity of Skin Thickness
-
Abstract Number: 711
Myopathy Is a Poor Prognostic Feature in Systemic Sclerosis: Results From the Canadian Scleroderma Research Group
-
Abstract Number: 712
Autoantibodies to Survival of Motor Neuron (SMN) Complex Are Common in Patients with Anti-U1RNP/Sm and Are Associated with Features of Scleroderma and Myopathy
-
Abstract Number: 713
Rpp25 Is a Major Target of Autoantibodies to the Th/to Complex As Measured by ELISA and a New Chemilumiscence Assay
-
Abstract Number: 714
Line Blot Assay, a Screening Test for Autoantibodies in Systemic Sclerosis (SSc)
-
Abstract Number: 716
Utility of Novel Patient-Reported Outcome Instruments in Predicting Cardiac Involvement and Pulmonary Hypertension in Patients with Systemic Sclerosis
-
Abstract Number: 719
Biomarkers of Pulmonary Hypertension in Patients with Scleroderma: A Case-Control Study
-
Abstract Number: 722
Systemic Sclerosis Associated Pulmonary Hypertension – Is Pulmonary Veno-Occlusive Disease As Common As They Say?
-
Abstract Number: 723
Renal Dysfunction and Disease Severity in Scleroderma-Associated Pulmonary Arterial Hypertension
-
Abstract Number: 724
Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension
-
Abstract Number: 1458
Left Ventricular Diastolic Dysfunction May Play a Role in Pathophysiology and Poor Prognosis of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
-
Abstract Number: 1459
Limited Utility of Pulmonary Function Tests and B-Type Natriuretic Peptide As Screening Tools for Pre-Capillary Pulmonary Hypertension in Patients with Systemic Sclerosis
-
Abstract Number: 1460
Unmasking Latent Pulmonary Arterial Hypertension by Fluid Challenge in Patients with Systemic Sclerosis
-
Abstract Number: 1461
Clinical Outcomes of Scleroderma Patients At High Risk for Pulmonary Hypertension. Analysis of the Pulmonary Hyparternsion Assessment and Recognition of Outcomes in Scleroderma Registry
-
Abstract Number: 1463
Pulmonary Hypertension and Interstitial Lung Disease within Pharos: Impact of Extent of Fibrosis and Pulmonary Physiology On Cardiac Hemodynamic Parameters
-
Abstract Number: 1464
Comparison of Baseline Characteristics of the Combined Response Index for Systemic Sclerosis (CRISS) Cohort to Patients Enrolled in Clinical Trials of Diffuse Systemic Sclerosis
-
Abstract Number: 1465
World Health Organization Classification of Pulmonary Hypertension and Survival in Systemic Sclerosis Patients in the Pharos Cohort
-
Abstract Number: 1466
Patients with Systemic Sclerosis Are Dying of Non-Systemic Sclerosis Related Causes, However Interstitial Lung Disease Remains the Predominant Systemic Sclerosis Related Cause of Death
-
Abstract Number: 1467
Association of Gastroesophageal Factors and Progression of Interstitial Lung Disease in the Canadian Scleroderma Research Group, a Large, Multicenter Database
-
Abstract Number: 1468
Patient Perspective Informs Core Sets, Constructs of Metrics and Communication Tools for Patients with Connective Tissue Disease Related Interstitial Lung Disease
-
Abstract Number: 1470
Clinical Features Associated with Anti-Th/to in Non-Scleroderma Patients – Sine Scleroderma?
-
Abstract Number: 1471
Differential Expression of Hepatocyte Growth Factor (HGF) in Patients with Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
-
Abstract Number: 1472
Enhanced Liver Fibrosis Test: A Further Step Toward Depiction of Fibrotic Process in Very Early Diagnosis of Systemic Sclerosis
-
Abstract Number: 1473
Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis
-
Abstract Number: 1474
Interferon-Inducible Chemokines Correlate with Disease Severity in Systemic Sclerosis
-
Abstract Number: 1475
Does Skin Gene Expression Profile Predict Response to Imatinib?
-
Abstract Number: 1476
Caveolin-1 Deficiency May Play a Role in the Predisposition of African Americans to SSc ILD
-
Abstract Number: 1477
Skin Autofluorescence As a Measure of Oxidative Stress in Systemic Sclerosis Is Not Affected by Skin Thickness, Erythema or Melanin
-
Abstract Number: 1478
Gender-Associated Differences in Disease Characteristics and Outcome in Systemic Sclerosis
-
Abstract Number: 1479
Early Versus Late Onset Systemic Sclerosis: Analysis of 1037 Patients From Rescle Registry
-
Abstract Number: 1480
The 15% Rule in Scleroderma: A Systematic Review of the Frequency of Organ Complications in Systemic Sclerosis
-
Abstract Number: 1481
A Double-Blind Placebo-Controlled Crossover Trial of the Alpha-2C Adrenoceptor Antagonist Orm-12741 for Prevention of Cold-Induced Vasospasm in Patients with Systemic Sclerosis
-
Abstract Number: 1482
Laser Speckle Contrast Imaging May Help in the Differential Diagnosis of Raynaud’s Phenomenon
-
Abstract Number: 1483
Predictors of Digital Ulcers in Systemic Sclerosis: Correlation Between Clinical and Hemodynamic Features, Capillaroscopy, Endothelium Dysfunction and Angiogenesis Biomarkers
-
Abstract Number: 1484
Investigating Determinants of Subjective and Objective Assessments of Peripheral Vascular Function in Primary Raynaud’s Phenomenon and Systemic Sclerosis
-
Abstract Number: 1485
Patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS) Present Esophageal and Anorectal Involvement: Data From a Single Centre
-
Abstract Number: 1486
Poor Outcome in Patients with Systemic Sclerosis and Myocardial Involvement: A Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance
-
Abstract Number: 1488
Prevalence and Risk Factors of Low Bone Mineral Density in Chinese Patients with Systemic Sclerosis: A Case-Control Study
-
Abstract Number: 1489
Peripheral Neuropathy: A Complication of Systemic Sclerosis